Merck (MRK) is the manufacturer of molnupiravir, a drug that is now being evaluated for treatment of covid-19. It can be used orally.

Many countries have placed advanced orders for this drug. This will approve the revenue and earnings for Merck.

Here are the financials for this stock:

Dividend yield: 2.93%
Trailing PE ratio: 35.95 X
Forward PE ratio: 13.09 X

The current stock price (4 Nov) is $90.54. It has increased 26% from a recent low of $71.68 on Sep 13. 

The highest price during the past year is $91.40.

I will monitor this stock and watch for further news.